Target intelligence / Profile preview

Long intergenic non-protein coding RNA 278 (LINC00278)

Target
LINC00278
Molecular classification
Long noncoding RNA (lncRNA), Micropeptide-encoding lncRNA, Other
01

Overview

Long intergenic non-protein coding RNA 278 (LINC00278) is a Y chromosome-encoded long noncoding RNA that harbors a small open reading frame in its first exon, encoding a 21-amino-acid micropeptide named YY1-blocking micropeptide (YY1BM). LINC00278 is predominantly cytoplasmic and its micropeptide product plays a tumor-suppressive role in male esophageal squamous cell carcinoma by blocking the interaction of the transcription factor YY1 and androgen receptor, which suppresses AR-dependent signaling (notably, eEF2K expression). LINC00278 expression and micropeptide translation are regulated through N6-methyladenosine (m6A) modification—smoking can decrease this m6A-mediated translation, linking environmental exposure to disease risk. No clinically approved drugs currently target LINC00278/YY1BM, but its unique role in male cancer biology makes it a notable disease-relevant target.

Other names
YY1-blocking micropeptideYY1BMNCRNA00278linc-TGIF2LY-2XLOC_008276ENSG00000231535OTTHUMG00000036157.1TCONS_00017607
02

Mechanism of action

For the micropeptide (YY1BM): blocks YY1–androgen receptor interaction, suppressing AR-driven eEF2K transcription and downstream tumor growth pathways

03

Biological functions

Inhibits interaction between YY1 and androgen receptorDownregulates eEF2K expression via AR signaling pathwayModulates apoptosisInfluences tumor progression (especially ESCC)Affected by posttranscriptional m6A modification
04

Disease associations

Cancer (esophageal squamous cell carcinoma in males)Other (potential relevance to male-specific disease mechanisms)
05

Safety considerations

No direct safety concerns reported; as a therapeutic target, LINC00278/YY1BM intervention would necessitate careful consideration of effects on androgen signaling and apoptosis in male tissues
06

Biomarkers

YY1BM levels (translation of YY1BM as a marker for ESCC susceptibility in males)m6A modification status of LINC00278 (post-transcriptional modification affected by smoking and predictive of micropeptide translation efficacy)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 278 (LINC00278).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 278 (LINC00278).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call